Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Lung Cancer

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0169-5002(94)91859-7PMID 7704502
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer

  2021cites this paper
• Differential Relapse Patterns for Non-small Cell Lung Cancer Subtypes Adenocarcinoma and Squamous Cell Carcinoma: Implications for Radiation Oncology.

  2019cites this paper
• Treatment Outcomes of Primary Pulmonary Lymphoepithelioma-like Carcinoma: a Series of 22 Patients and Treatment Strategy Review

  2013cites this paper
• Molecular imaging in the combined modality treatment of lung cancer

  2010cites this paper
• Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

  2010cites this paper
• Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.

  2010cites this paper
• HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.

  2008cites this paper
• Phase II Study of Induction Irinotecan + Cisplatin Chemotherapy Followed by Concurrent Irinotecan + Cisplatin Plus Twice-Daily Thoracic Radiotherapy.

  2007cites this paper
• Limited Field Radiotherapy Concomitant with Cisplatin/Etoposide Followed by Consolidation Docetaxel for the Treatment of Inoperable Stage III Non-Small Cell Lung Cancer.

  2007cites this paper
• Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour

  2006cites this paper
• Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.

  2006cites this paper
• Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.

  2006cites this paper
• Induction chemotherapy, concurrent chemoradiation, and surgery for Pancoast tumor. Mature results of a feasibility trial

  2006cites this paper
• Thoracic radiation therapy for limited-stage small-cell lung cancer: unanswered questions.

  2005cites this paper
• Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.

  2005cites this paper
• Radiation-induced pulmonary toxicity in non-small cell lung cancer

  2005cites this paper
• Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer.

  2004cites this paper
• Gefitinib as salvage therapy in pretreated patients with advanced non-small cell lung cancer. Data from a compassionate use program.

  2004cites this paper
• Surgery after multimodality treatment for non-small-cell lung cancer.

  2004cites this paper
• Small Cell Lung Cancer: Limited Disease

  2004cites this paper
• Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.

  2003cites this paper
• Hemoglobin as an Independent Prognostic Factor in the Radiotherapy of Head and Neck Tumors

  2003cites this paper
• Cisplatin plus vinorelbine as induction chemotherapy followed by surgery in the treatment of stage IIIB non-small cell lung cancer. Final results of a multicenter phase II study.

  2003cites this paper
• Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach.

  2003cites this paper
• First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy.

  2003cites this paper
• Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.

  2003cites this paper
• Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients.

  2002cites this paper
• Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.

  2002cites this paper
• Curative radiotherapy for a second primary lung cancer arising after pneumonectomy -- techniques and results.

  2002cites this paper
• [Postoperative irradiation of bronchial cancers: has the page been turned?].

  1999cites this paper
• Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial

  1999cites this paper
• L'irradiation postoperatoire des cancers bronchiques: La page est-elle tournee?

  1999cites this paper
• Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results.

  1999cites this paper
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee.

  1999cites this paper
• [Radiotherapy in a multidisciplinary approach].

  1998cites this paper
• Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.

  1998cites this paper
• Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

  1998cites this paper
• [Limitations and perspectives of postoperative radiotherapy in bronchial cancer].

  1998cites this paper
• Induction treatment for resectable non-small-cell lung cancer.

  1997cites this paper
• Stage III nonsmall cell lung cancer: still a challenge for the radiation oncologist.

  1997cites this paper
• Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee.

  1997cites this paper
• Definition of “death from other diseases” in the calculation of survival rate in lung cancer cases after surgery

  1997cites this paper
• Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.

  1996cites this paper